1. Home
  2. WTO vs MTNB Comparison

WTO vs MTNB Comparison

Compare WTO & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

HOLD

Current Price

$9.21

Market Cap

5.1M

Sector

Technology

ML Signal

HOLD

Logo Matinas Biopharma Holdings Inc.

MTNB

Matinas Biopharma Holdings Inc.

HOLD

Current Price

$0.62

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTO
MTNB
Founded
2008
2013
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.2M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
WTO
MTNB
Price
$9.21
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.0M
22.4K
Earning Date
03-18-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.84
EPS
N/A
N/A
Revenue
N/A
$119,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.48
52 Week High
$9.60
$3.09

Technical Indicators

Market Signals
Indicator
WTO
MTNB
Relative Strength Index (RSI) 90.65 41.42
Support Level $0.58 $0.57
Resistance Level N/A $0.66
Average True Range (ATR) 0.81 0.06
MACD 0.71 -0.01
Stochastic Oscillator 100.00 7.00

Price Performance

Historical Comparison
WTO
MTNB

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Share on Social Networks: